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From error to tetraploid
 
naphase is not the point of no return, say Qinghua Shi
and Randall King (Harvard Medical School, Boston,
MA). If cells make errors in anaphase chromosome
segregation, they mount a rescue operation. The final stages of
cytokinesis shut down, producing tetraploid cells that might
even be able to regenerate functional diploid cells.
Shi and King started out looking for different chromosome
missegregation rates in various cell lines. They noticed that the
rate of missegregation was 45–166-fold higher in spontaneously
arising binucleated cells than in cells with normal divisions. In
time-lapse experiments, these aberrant cells did not delay in
mitosis but reversed their division process just before cytokinesis
completion. The thin, remaining bridge between dividing cells
opened back up, yielding a binucleate cell.
Extrapolating from experiments using probes for four
chromosomes, it is likely that there is a segregation error during
virtually all divisions that produce new binucleates. Chromo-
somes were not always obstructing the division furrow, so the
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ingle-stranded DNA (ssDNA) and protein can mimic each other,
according to Elena Bochkareva, Lilia Kaustov, Cheryl Arrowsmith,
Alexey Bochkarev (University of Toronto, Canada), and colleagues.
They find structural evidence that ssDNA and a helix from p53 both bind to
replication protein A (RPA) in the same position and the same manner—with S
Binding to RPA is similar for both p53 (left) and ssDNA (right).
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negative groups poking out and aromatic groups buried in a cleft.
The binding may al-
low p53 to titrate ssDNA
during its response to
DNA damage. Before
damage, p53 is bound
to RPA and thus pre-
vented from acting as a
transcriptional activa-
tor. When RPA first re-
sponds to the ssDNA
exposed by DNA dam-
age, it has additional
domains that are better
specialized for binding ssDNA, so p53 probably comes along for the
ride. This exposes p53 to two signals about damage intensity: local kinases
and ssDNA itself. The Canadian group shows that ssDNA can compete
with p53 for binding to the same site on RPA. Released p53 should be
free to activate transcription.
Yet more regulation comes from the phosphorylation of another
subunit of RPA. This modified form of RPA is even better than ssDNA at
displacing p53 from RPA, although the phosphorylation takes a while to
accumulate. A combination of these regulators must somehow communicate
the amount of DNA damage to p53 so it can help the cell to choose between
apoptosis and the induction of DNA repair. 
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NO link to destruction
 
wo domains of cell behavior—protein mod-
ification by nitric oxide (NO) and ubiquitin-
dependent protein destruction by the N-end
rule pathway—have been united by Rong-Gui Hu,
Jun Sheng, Alexander Varshavsky, and colleagues
(Caltech, Pasadena, CA). They find that NO
oxidizes NH
 
2
 
-terminal cysteines on certain pro-
teins, thus marking them for future destruction.
NO could therefore act as a very spatially and
temporally delimited source of a destruction signal.
Cysteine was already known to be destabi-
lizing when present as an NH
 
2
 
-terminal residue,
and there were hints that its oxidation might be in-
volved. The Caltech group now find that oxidation
is essential to make the cysteine a substrate for
arginyl transferase. The arginylated protein is then
destroyed by the rest of the N-end rule pathway.
One substrate of this pathway is shown to
be the GTPase-activating protein RGS4. It is no
longer arginylated and is more abundant in vivo
when either arginyl transferase is deleted or NO
levels are reduced pharmacologically. Two
other RGS proteins are also substrates, and 
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uncharacterized proteins are candidates.
NO’s short half-life, says Varshavsky, gives
you the possibility of regulating proteins through
on a subcellular level. NO-related drugs for
regulating blood vessels and heart function may
become more specific if they could be targeted
to the N-end rule’s part of NO signaling. 
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pair think it is possible that a dedicated signaling mechanism
may detect segregation errors and put the brakes on cytokinesis.
The virtues of opting out of the diploid world depend on what
happens to tetraploids. David Pellman (Harvard Medical School)
has recently shown that tetraploids lacking p53 promote tumor-
igenesis, but tetraploids with p53 may not behave so badly. There
may even, suggests King, be a pathway from tetraploids back to
functional, nonaneuploid diploids. “If that were true,” he says,
“there would be a full pathway for the resolution of errors.” 
 
References: Fujiwara, T., et al. 2005. 
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Aberrant segregation (right) yields tetraploid binucleates.
K
I
N
G
/
M
A
C
M
I
L
L
A
N
 
1713rr  Page 407  Wednesday, October 26, 2005  3:15 AM